ArticleRheumatology (Oxford, England)2026

Correction to: Baricitinib for Takayasu arteritis refractory to TNF-α inhibitors: a multicentre, single-arm trial.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.